ArticleResearch and practice in thrombosis and haemostasis2025
Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometry.
Armando Tripodi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.